Skip to main content

Advertisement

Log in

Analysis of c-myc, PAI-1 and uPAR in patients with incisional hernias

  • Original Article
  • Published:
Hernia Aims and scope Submit manuscript

Abstract

Background

Disturbed wound healing leading to alterations in collagen composition has been thought to play a key role in the pathogenesis of incisional hernia formation. The aim of the present study was to further characterise the scarring process in such patients.

Methods

Mature skin scars from patients with either primary or recurrent incisional hernias were compared to mature abdominal skin scars from patients without hernias. The distribution of collagen types I and III was analysed using crosspolarisation microscopy. Expression of c-myc—a parameter for cell differentiation and proliferation—and of PAI-1 and uPAR—parameters of the proteolytic cascade in wound healing—were determined by immunohistochemistry.

Results

In agreement with previous studies, decreased collagen I/III ratios were found in patients with incisional hernias. In these patients, c-myc levels were significantly elevated whereas plasminogen activator inhibitor-1 (PAI-1) and urokinase-plasminogen activator receptor (uPAR) levels were only slightly increased. In contrast to controls, a significant correlation between c-myc, PAI-1 and uPAR expression and collagen I/III ratios was found in patients with incisional hernias.

Conclusion

The differential correlation of collagen types and expression of c-myc, PAI-1 and uPAR within the scar tissue might represent a causal factor in incisional hernia formation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. McEntyre RL, Raffensperger JG (1977) Surgical complications of Ehlers-Danlos syndrome in children. J Pediatr Surg 12:531–535

    Article  PubMed  CAS  Google Scholar 

  2. Adye B, Luna G (1998) Incidence of abdominal wall hernia in aortic surgery. Am J Surg 175:400–402

    PubMed  CAS  Google Scholar 

  3. Girotto JA, Malaisrie SC, Bulkely G, Manson PN (2000) Recurrent ventral herniation in Ehlers-Danlos syndrome. Plast Reconstr Surg 106:1520–1526

    Article  PubMed  CAS  Google Scholar 

  4. Augestad KM, Wilsgaard T, Solberg S (2002) Incisional hernia after surgery for abdominal aortic aneurysm. Tidsskr Nor Laegeforen 122:22–24

    PubMed  Google Scholar 

  5. Papadimitriou D, Pitoulias G, Papaziogas B, Koutsias S, Vretzakis G, Argiriadou H, Papaziogas T (2002) Incidence of abdominal wall hernias in patients undergoing aortic surgery for aneurysm or occlusive disease. Vasa 31:111–114

    Article  PubMed  CAS  Google Scholar 

  6. Sorensen LT, Friis E, Jorgensen T, Vennits B, Andersen BR, Rasmussen GI, Kjaergaard J (2002) Smoking is a risk factor for recurrence of groin hernia. World J Surg 26:397–400

    Article  PubMed  Google Scholar 

  7. Sorensen LT, Hemmingsen UB, Kirkeby LT, Kallehave F, Jorgensen LN (2005) Smoking is a risk factor for incisional hernia. Arch Surg 140:119–123

    Article  PubMed  Google Scholar 

  8. Read RC (1970) Attenuation of the rectus sheath in inguinal herniation. Am J Surg 120:610–614

    Article  PubMed  CAS  Google Scholar 

  9. Bellon JM, Bujan J, Honduvilla NG, Jurado F, Gimeno MJ, Turnay J, Olmo N, Lizarbe MA (1997) Study of biochemical substrate and role of metalloproteinases in fascia transversalis from hernial processes. Eur J Clin Invest 27:510–516

    Article  PubMed  CAS  Google Scholar 

  10. Klinge U, Si ZY, Zheng H, Schumpelick V, Bhardwaj RS, Klosterhalfen B (2000) Abnormal collagen I to III distribution in the skin of patients with incisional hernia. Eur Surg Res 32:43–48

    Article  PubMed  CAS  Google Scholar 

  11. Bellon JM, Bajo A, Ga-Honduvilla N, Gimeno MJ, Pascual G, Guerrero A, Bujan J (2001) Fibroblasts from the transversalis fascia of young patients with direct inguinal hernias show constitutive MMP-2 overexpression. Ann Surg 233:287–291

    Article  PubMed  CAS  Google Scholar 

  12. Klinge U, Si ZY, Zheng H, Schumpelick V, Bhardwaj RS, Klosterhalfen B (2001) Collagen I/III and matrix metalloproteinases (MMP) 1 and 13 in the fascia of patients with incisional hernias. J Invest Surg 14:47–54

    Article  PubMed  CAS  Google Scholar 

  13. Si Z, Rhanjit B, Rosch R, Rene PM, Klosterhalfen B, Klinge U (2002) Impaired balance of type I and type III procollagen mRNA in cultured fibroblasts of patients with incisional hernia. Surgery 131:324–331

    Article  PubMed  Google Scholar 

  14. Rosch R, Junge K, Knops M, Lynen P, Klinge U, Schumpelick V (2003) Analysis of collagen-interacting proteins in patients with incisional hernias. Langenbecks Arch Surg 387:427–432

    PubMed  CAS  Google Scholar 

  15. Salameh JR, Talbott LM, May W, Gosheh B, Vig PJ, McDaniel DO (2007) Role of biomarkers in incisional hernias. Am Surg 73:561–567

    PubMed  CAS  Google Scholar 

  16. Junge K, Klinge U, Rosch R, Mertens PR, Kirch J, Klosterhalfen B, Lynen P, Schumpelick V (2004) Decreased collagen type I/III ratio in patients with recurring hernia after implantation of alloplastic prostheses. Langenbecks Arch Surg 389:17–22

    Article  PubMed  Google Scholar 

  17. Remmele W SH (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138–140

    PubMed  CAS  Google Scholar 

  18. Arumugam S, Jang YC, Chen-Jensen C, Gibran NS, Isik FF (1999) Temporal activity of plasminogen activators and matrix metalloproteinases during cutaneous wound repair. Surgery 125:587–593

    PubMed  CAS  Google Scholar 

  19. Mignatti P, Rifkin DB (1996) Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 49:117–137

    PubMed  CAS  Google Scholar 

  20. Nicholl SM, Roztocil E, Davies MG (2006) Plasminogen activator system and vascular disease. Curr Vasc Pharmacol 4:101–116

    Article  PubMed  CAS  Google Scholar 

  21. Pelengaris S, Khan M (2003) The many faces of c-MYC. Arch Biochem Biophys 416:129–136

    Article  PubMed  CAS  Google Scholar 

  22. Hu Z, Lou L, Luo S (2002) Experimental study of the expression of c-myc, c-fos and proto-oncogenes on hypertrophic and scars. Zhonghua Zheng Xing Wai Ke Za Zhi 18:165–167

    PubMed  Google Scholar 

  23. Prendergast GC, Diamond LE, Dahl D, Cole MD (1990) The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1. Mol Cell Biol 10:1265–1269

    PubMed  CAS  Google Scholar 

  24. Stojadinovic O, Brem H, Vouthounis C, Lee B, Fallon J, Stallcup M, Merchant A, Galiano RD, Tomic-Canic M (2005) Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 167:59–69

    PubMed  CAS  Google Scholar 

Download references

Acknowledgement

We are grateful to Mrs. Ellen Krott for most excellent and careful assistance during this investigation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Rosch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosch, R., Binnebösel, M., Junge, K. et al. Analysis of c-myc, PAI-1 and uPAR in patients with incisional hernias. Hernia 12, 285–288 (2008). https://doi.org/10.1007/s10029-007-0311-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10029-007-0311-7

Keywords

Navigation